The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -63.35%.However, over the last six months, we can see a stronger performance of -63.13%. Over the last 30 days, the price of MURA has leaped by -67.76%. And in the last five days, it has fallen by -69.35%.
Mural Oncology plc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $5.12 on 04/01/24 and a low of $1.28 for the same time frame on 03/28/25.
52-week price history of MURA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Mural Oncology plc’s current trading price is -76.95% away from its 52-week high, while its distance from the 52-week low is -7.84%. The stock’s price range during this period has varied between$1.28 and $5.12. The Mural Oncology plc’s shares, which operate in the Healthcare, saw a trading volume of around 0.84 million for the day, a figure considerably higher than their average daily volume of 0.24 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Mural Oncology plc (MURA) has experienced a quarterly decline of -63.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.33M and boasts a workforce of 116 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.6321, with a change in price of -2.3400. Similarly, Mural Oncology plc recorded 229,828 in trading volume during the last 100 days, posting a change of -66.48%.
MURA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MURA stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.02.
MURA Stock Stochastic Average
As of today, Mural Oncology plc’s raw stochastic average for the last 50 days stands at 1.66%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 1.86%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 1.70% and 7.78%, respectively.
